EGLT ALERT: Rosen Law Firm Reminds Egalet Corporation Investors of Important Deadline in Class Action – EGLT

NEW YORK, March 10, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Egalet Corporation securities (NASDAQ:EGLT) from December 15, 2015 through January 9, 2017, inclusive (the “Class Period”) of the important March 28, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Egalet investors under the federal securities laws.

To join the Egalet class action, go to http://rosenlegal.com/cases-1046.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about Egalet’s business, operations, and prospects, including that: (1) Egalet misrepresented ARYMO ER’s oral abuse-deterrent profile, (2) Egalet falsely or misleadingly overstated ARYMO ER’s chances to receive the oral abuse-deterrent labeling, (3) the NDA for ARYMO ER lacked sufficient data to support the oral-labeling claims, (4) the label was likely not to include the oral abuse-deterrent claims, and (5) as a result, Egalet’s statements, as well as Defendants’ statements about Egalet’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 28, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1046.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY  10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com